Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain
- PMID: 35859868
- PMCID: PMC9290002
- DOI: 10.1021/acsmedchemlett.2c00084
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain
Abstract
Human African Trypanosomiasis (HAT) is a neglected tropical disease widespread in sub-Saharan Africa. Rhodesain, a cysteine protease of Trypanosoma brucei rhodesiense, has been identified as a valid target for the development of anti-HAT agents. Herein, we report a series of urea-bond-containing Michael acceptors, which were demonstrated to be potent rhodesain inhibitors with K i values ranging from 0.15 to 2.51 nM, and five of them showed comparable k 2nd values to that of K11777, a potent antitrypanosomal agent. Moreover, most of the urea derivatives exhibited single-digit micromolar activity against the protozoa, and the presence of substituents at the P3 position appears to be essential for the antitrypanosomal effect. Replacement of Phe with Leu at the P2 site kept unchanged the inhibitory properties. Compound 7 (SPR7) showed the best compromise in terms of rhodesain inhibition, selectivity, and antiparasitic activity, thus representing a new lead compound for future SAR studies.
© 2022 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures





Similar articles
-
Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.Molecules. 2022 Jun 11;27(12):3765. doi: 10.3390/molecules27123765. Molecules. 2022. PMID: 35744891 Free PMC article.
-
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis.Bioorg Chem. 2023 Aug;137:106587. doi: 10.1016/j.bioorg.2023.106587. Epub 2023 May 4. Bioorg Chem. 2023. PMID: 37163812
-
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).J Med Chem. 2017 Aug 24;60(16):6911-6923. doi: 10.1021/acs.jmedchem.7b00405. Epub 2017 Aug 11. J Med Chem. 2017. PMID: 28763614
-
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis.Mini Rev Med Chem. 2016;16(17):1374-1391. doi: 10.2174/1389557515666160509125243. Mini Rev Med Chem. 2016. PMID: 27156518 Review.
-
Update on relevant trypanosome peptidases: Validated targets and future challenges.Biochim Biophys Acta Proteins Proteom. 2021 Feb;1869(2):140577. doi: 10.1016/j.bbapap.2020.140577. Epub 2020 Nov 30. Biochim Biophys Acta Proteins Proteom. 2021. PMID: 33271348 Review.
Cited by
-
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors.Eur J Med Chem. 2023 Feb 5;247:115021. doi: 10.1016/j.ejmech.2022.115021. Epub 2022 Dec 15. Eur J Med Chem. 2023. PMID: 36549112 Free PMC article.
-
Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents.ACS Med Chem Lett. 2024 Mar 1;15(5):602-609. doi: 10.1021/acsmedchemlett.3c00562. eCollection 2024 May 9. ACS Med Chem Lett. 2024. PMID: 38746883 Free PMC article.
-
Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense.Int J Mol Sci. 2022 Nov 21;23(22):14470. doi: 10.3390/ijms232214470. Int J Mol Sci. 2022. PMID: 36430948 Free PMC article.
-
Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense.Int J Mol Sci. 2023 May 9;24(10):8477. doi: 10.3390/ijms24108477. Int J Mol Sci. 2023. PMID: 37239824 Free PMC article.
-
Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria.Int J Mol Sci. 2024 Apr 17;25(8):4410. doi: 10.3390/ijms25084410. Int J Mol Sci. 2024. PMID: 38673995 Free PMC article.
References
-
- World Health Organization . Human African Trypanosomiasis (sleeping sickness). World Health Organization, 2021https://www.who.int/trypanosomiasis_african/en/ (accessed January 22, 2022).
-
- Trindade S.; Rijo-Ferreira F.; Carvalho T.; Pinto-Neves D.; Guegan F.; Aresta-Branco F.; Bento F.; Young S. A.; Pinto A.; Van Den Abbeele J.; Ribeiro R. M.; Dias S.; Smith T. K.; Figueiredo L. M. Trypanosoma brucei parasites occupy and functionally adapt to the adipose tissue in mice. Cell Host Microbe 2016, 19 (6), 837–848. 10.1016/j.chom.2016.05.002. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Chemical Information
Miscellaneous